Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis

11 Jun 2021

Abstract excerpt

With the increasingly early stage lung squamous cell carcinoma (LUSC) being discovered, there is an urgent need for a comprehensive analysis of the prognostic characteristics of early stage LUSC. Here, we developed an immune-related gene signature for outcome prediction of early stage LUSC based on three independent cohorts. Differentially expressed genes (DEGs) were identified using CIBERSORT and ESTMATE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34177903
DOI: 10.3389/fimmu.2021.665407

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma PrognosisPMID 34177903Read ↗

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity Read ↗

A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Development of a Prognostic Model Based on Differentially Expressed Immune Genes of Lung AdenocarcinomaSemantic proximity Read ↗

Validation of an Immune-related Gene Pair Index as a Prognostic Marker of Early-Stage Lung Squamous Cell CarcinomaSemantic proximity Read ↗

The construction and validation of integrated immune and metabolic gene signatures for clinical prognostic model of lung squamous cell carcinomaSemantic proximity Read ↗

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosisSemantic proximity Read ↗

Identification and Validation of a Tumor Microenvironment‐Related Gene Signature for Prognostic Prediction in Advanced‐Stage Non‐Small‐Cell Lung CancerSemantic proximity Read ↗

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosisSemantic proximity Read ↗

A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinomaSemantic proximity Read ↗

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read ↗

Development of an anoikis-related gene signature for lung squamous cell carcinoma to predict prognosis, immune landscape, and immunotherapy responseSemantic proximity Read ↗

Establishment and validation of an immune-associated signature in lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.